AIM-101

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAIM-101
Drug Alias NameAIM-101 (AIM Therapeutics)AIM-101
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNeutrophil adhesion inhibitorsNeutrophil infiltration inhibitors
TargetsUpdating
Therapy Area/IndicationsInflammationSpinal Cord InjuriesPulmonary Disease, Chronic Obstructive +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAim Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAim Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsInflammationSpinal Cord InjuriesPulmonary Disease, Chronic Obstructive +[4] 

Other Information

ATC CodeN/A
Related LinksN/A